Wenjun Chen
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A chemical screen identifies PRMT5 as a therapeutic vulnerability for paclitaxel-resistant triple-negative breast cancer.
Journal: Cell chemical biology
Published: November 27, 2023
Type-I protein arginine methyltransferase inhibition primes anti-programmed cell death protein 1 immunotherapy in triple-negative breast cancer.
Journal: Cancer
Published: September 20, 2023
Targeting TAF1 with BAY-299 induces antitumor immunity in triple-negative breast cancer.
Journal: Biochemical and biophysical research communications
Published: April 06, 2023
PRMT inhibition induces a viral mimicry response in triple-negative breast cancer.
Journal: Nature chemical biology
Published: June 22, 2021
GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer.
Journal: Nature communications
Published: August 08, 2019
PRMT5 inhibition disrupts splicing and stemness in glioblastoma.
Journal: Nature communications
Published: July 22, 2019
Nod-like receptor pyrin containing 3 (NLRP3) in the post-mortem frontal cortex from patients with bipolar disorder: A potential mediator between mitochondria and immune-activation.
Journal: Journal of psychiatric research
Published: June 04, 2015
The Potential Role of the NLRP3 Inflammasome as a Link between Mitochondrial Complex I Dysfunction and Inflammation in Bipolar Disorder.
Journal: Neural plasticity
Published: August 06, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026